Comparison of Top Two Shares of the Day: BRF S.A. (NYSE:BRFS), Array BioPharma Inc. (NASDAQ:ARRY)


BRF S.A. (NYSE:BRFS) closed at $6.18 on the last trading session with an decrease of -3.29%, whereas, it previously closed at $6.39. The company has a market capitalization of $5.07 Billion. The company traded shares of 4.49 Million on the trading day while its three month average volume stands at 2.12 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of BRF S.A. (NYSE:BRFS) produced diluted EPS of 0.22. The EPS estimate for next year as estimated by analysts is at 0.44 while EPS for next quarter is estimated at 0.19. Earnings per Share growth for this year is reported at -84.5, while the analysts estimated the EPS growth for next year at 0.44% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -33.4%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of BRF S.A. (NYSE:BRFS) is at 28.35 while the forward p/e is at 14.21. The P/S or Price to Sales ratio of BRF S.A. (NYSE:BRFS) stands at 0.76 and Price to Book or P/B for the most recent quarter stands at 3.07. The Price to Free Cash Flow ratio or P/FCF is reported at 11.53. The quick ratio and the current ratio of BRF S.A. (NYSE:BRFS) are reported at 0.8 and 1.2 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for BRF S.A. (NYSE:BRFS) stands at -5.8, -35.3 and 0.4 respectively

The trailing twelve month Revenue of BRF S.A. (NYSE:BRFS) is reported at 6.68 Billion with income of 177 Million. The outstanding shares of BRF S.A. (NYSE:BRFS) are 819.91 Million. The institutional Ownership of the shares of 16.9 stands at 0.80%, this figure is increased 3.56 in the last six months. The insider ownership for the shares of BRF S.A. (NYSE:BRFS) is ticked at 1.7%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for BRF S.A. (NYSE:BRFS) is the Mean Target Price estimated by the analysts which stands at 11.2. The 52 week high of BRF S.A. (NYSE:BRFS) is placed at 9.96 and 52 week low is standing at 5.02.

Performance wise the shares of BRF S.A. (NYSE:BRFS) fell down -11.59% for the week, it also fell -17.49% for the monthly performance, while for the quarter it went up -27.21%. The shares decrease -32.24% for the half year and plummeted for the Year-To-Date performance. The shares of BRF S.A. (NYSE:BRFS) grew 5.28% for the yearly performance.

Array BioPharma Inc. (NASDAQ:ARRY)